Head of Department
Transformation , planning , and business development department , Tabuk health cluster , Saudi Arabia., Saudi Arabia
khalidah A. Alenzi is a pharmacist With over 17 years of experience specializing in drug information, health technology assessment, pharmacoeconomics, and pharmacovigilance.
She got her undergraduate degree in pharmaceutical sciences from King Saud University in 2006.
Additionally, she earned her MBA from PFSU Business School in 2016 and a Certificate in Health Economics and Outcome research from The University of Washington in 2019.
She is the Regional Drug Information and Pharmacovigilance Center supervisor at Tabuk's Directorate of Health Affairs and executive director of transformation, planning, and business development in the tabuk health cluster. In addition, khalidah is a representative of KSA in the ISoP Middle East Pharmacovigilance chapter and an examiner in SPLE at SCFHS.
Moreover, she is also a Quality Fellow, certified by qualification and practice, and earned many strategic planning and KPI certifications.
As a supervisor, she works on 937 drug consultation hotlines and is a member of many national committees, such as the Saudi Commission for Health Specialties and the Ministry of Health. In addition, she shared for preparing many national treatment guidelines, disease registries, and the budget impact of different diseases.